The salient point, which I keep missing, is payers reimbursing for Sovaldi/Riba (GT2) would get caught up in the price increase for standalone Sovaldi. Not just backbone poachers.
It was real late (my time) when I typed that message.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.